| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Bain Capital Life Sciences | - | Yes | - | Detail |
| Perceptive Advisors | - | Yes | - | Detail |
| T. Rowe Price | - | - | - | Detail |
| Andreessen Horowitz | - | - | - | Detail |
| Soleus Capital | - | - | - | Detail |
| Section 32 | - | - | - | Detail |
| Sands Capital Ventures | - | - | - | Detail |
| Rock Springs Capital | - | - | - | Detail |
| Roche Venture Fund | - | - | - | Detail |
| RA Capital Management | - | - | - | Detail |
| Polaris Partners | - | - | - | Detail |
| Novartis | - | - | - | Detail |
| Kaiser Permanente Ventures | - | - | - | Detail |
| Janus Henderson Investors | - | - | - | Detail |
| GV | - | - | - | Detail |
| Fidelity Management and Research Company | - | - | - | Detail |
| Farallon Capital Management | - | - | - | Detail |
| EcoR1 Capital | - | - | - | Detail |
| DCVC | - | - | - | Detail |
| Cormorant Asset Management | - | - | - | Detail |
| Catalio Capital Management | - | - | - | Detail |
| BrightEdge Fund | - | - | - | Detail |
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Aug 28, 2017 | Series A | $ 7M | Andreessen Horowitz,Anne Wojcicki,etc. | Detail |
| Jul 24, 2019 | Series B | $ 160M | Andreessen Horowitz,Artis Ventures (AV),etc. | Detail |
| Jun 9, 2016 | Seed | $ 5.55M | Andreessen Horowitz,DCVC,etc. | Detail |
| Mar 1, 2017 | Series A | $ 65M | Agent Capital,Allen & Company,etc. | Detail |
| Dec 1, 2014 | Seed | 0 | Loxbridge Research | Detail |